PEOPLE - Inion makes appointment:
This article was originally published in Clinica
Finnish company Inion (Tampere, Finland), which develops novel biodegradeable medical implants, has appointed Paul Garvey to the board of directors as a non-executive director. Mr Garvey continues as group finance director for Anglo-Norwegian diagnostic products company Axis-Shield.
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.